CTS Research Consortium was established to further CTS’s leadership in infectious disease research. This collaboration between Vitalant Research Institute, Carter BloodCare, OneBlood, ITxM, New York Blood Center and Bloodworks Northwest will provide a wealth of data for the development of future hypothesis-based research studies.
In April, CTS becomes the first blood donor testing organization in the US to implement Zika testing...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
In October, due to demand from existing healthcare partners, CTS began testing blood donors for anti...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...